EGFR and pancreatic neoplasm: Recent studies have also suggested that SERPINE1 plays an important role in breast and pancreatic cancer (44, 45), and that the overexpression of SERPINE1 could induce activation of the EGFR signaling pathway in breast cancer cells (44).